Inspire Pharm Ltd 14440805 false 2023-11-01 2024-10-31 2024-10-31 Digita Accounts Production Advanced 6.30.9574.0 true 14440805 2023-11-01 2024-10-31 14440805 2024-10-31 14440805 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 14440805 bus:Micro-entities 2023-11-01 2024-10-31 14440805 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 14440805 bus:FilletedAccounts 2023-11-01 2024-10-31 14440805 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 14440805 bus:RegisteredOffice 2023-11-01 2024-10-31 14440805 bus:Director1 2023-11-01 2024-10-31 14440805 bus:Director2 2023-11-01 2024-10-31 14440805 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 14440805 countries:EnglandWales 2023-11-01 2024-10-31 14440805 2022-10-25 2023-10-31 14440805 2023-10-31 14440805 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 iso4217:GBP xbrli:pure

Registration number: 14440805

Prepared for the registrar
 

Inspire Pharm Ltd

Unaudited Financial Statements

for the Year Ended 31 October 2024

 

Inspire Pharm Ltd

Contents

Company Information

1

Directors' Report

2

Balance Sheet

3

Notes to the Financial Statements

4

 

Inspire Pharm Ltd

Company Information

Directors

Nemesh Patel

Kinali Patel

Registered office

Emsworth Pharmacy
2-4 Central Buildings
West Street
Emsworth
United Kingdom
PO10 7DU

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Inspire Pharm Ltd

Directors' Report for the Year Ended 31 October 2024

The directors present their report and the financial statements for the year ended 31 October 2024.

This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Directors of the company

The directors who held office during the year were as follows:

Nemesh Patel

Kinali Patel

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved by the Board on 11 June 2025 and signed on its behalf by:


Nemesh Patel
Director

 

Inspire Pharm Ltd

(Registration number: 14440805)
Balance Sheet as at 31 October 2024

2024
£

2023
£

Creditors: Amounts falling due within one year

(440)

(20)

Accruals and deferred income

(165)

(150)

 

(605)

(170)

Capital and reserves

(605)

(170)

For the financial year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Approved and authorised by the Board on 11 June 2025 and signed on its behalf by:
 

.........................................
Nemesh Patel
Director

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

Inspire Pharm Ltd

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Emsworth Pharmacy
2-4 Central Buildings
West Street
Emsworth
United Kingdom
PO10 7DU

These financial statements were authorised for issue by the Board on 11 June 2025.

Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 105 micro entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

1

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).